TL;DR
This paper uses game theory to model the complex process of transferring pharmaceutical research from universities to industry. It reveals that a delicate balance of incentives, rather than just penalties, is crucial for faculty inventors to "comply with the rules" and ensure successful technology transfer, ultimately benefiting both academia and industry.
What Problem Does This Paper Address?
The pharmaceutical industry relies heavily on innovation, and a significant portion of this innovation originates from university research. However, the path from a lab discovery to a marketable drug is fraught with challenges, particularly in the "technology transfer" phase. A major hurdle is the "speculative behavior" of faculty inventors, who may bypass university technology transfer offices and directly partner with companies or start their own ventures. This can lead to inefficiencies, lost intellectual property for universities, and a low overall success rate for transforming valuable research into real-world applications. The paper aims to understand the factors influencing this behavior and propose strategies to improve the success rate of pharmaceutical technology transfer.
Methods
The authors employ two game-theoretic models:
- Evolutionary Game: This model analyzes the dynamic interactions between faculty inventors and universities. It explores how their strategies (e.g., "comply with the rules" vs. "speculate" for inventors, and "supervision" vs. "non-supervision" for universities) evolve over time to reach a stable equilibrium.
- Stackelberg Game: This model examines the relationship between faculty inventors and pharmaceutical companies, where the inventor acts as the leader and the company as the follower. It focuses on how decisions about technology transaction prices are made.
These theoretical models are then complemented by numerical simulations using MATLAB to explore the impact of various parameters on the decision-making behavior of the involved parties.
Datasets
Not discussed in the paper. The authors mention using data obtained from visiting several key universities in China for parameter estimation and model validation, but no specific datasets are detailed.
Key Insights and Ideas
- Incentives over Penalties: While universities might consider increasing penalties for "speculative" behavior, the research suggests this is often ineffective. Instead, increasing the income distribution coefficient and rewards for faculty inventors is a more potent strategy to encourage compliance.
- The "Sweet Spot" for Income Distribution: The optimal income distribution coefficient for faculty inventors is not a simple linear relationship. It depends on the transformation success rate, with a critical point where higher distribution can either encourage or discourage compliance.
- Transaction Price Matters: Pharmaceutical companies play a crucial role by setting technology transaction prices. Higher prices can incentivize "speculation" by inventors, while appropriate pricing, considering the technical gap and university supervision, is key to successful transfer.
- Future Work Affects Risk Appetite: Younger faculty inventors, with more future working years, may be more inclined to take risks ("speculate") for potentially higher immediate gains. Older inventors, with more to lose in terms of reputation, may be more risk-averse.
- Information Asymmetry is Key: The models acknowledge that perfect information is unrealistic. The "speculative" behavior and the need for agreements stem from this inherent uncertainty about other parties' intentions.
Key Results
The study identifies several key factors influencing the success of pharmaceutical technology transfer:
- Transformation Success Rate: A higher success rate is negatively correlated with a faculty inventor's willingness to "comply with the rules," leading to more "speculative" behavior.
- Income Distribution Coefficient (γ): This coefficient's impact is nuanced and depends on the transformation success rate. It can either encourage or discourage compliance.
- Faculty Inventor's Future Working Years (n): Willingness to "comply with the rules" is inversely proportional to future working years.
- Technological Transaction Price (ps): This price is directly proportional to the transformation success rate and the expected return difference.
- Penalties (Cr): While intended to deter "speculation," increased penalties can paradoxically decrease the willingness to "comply with the rules" when the transformation success rate is high.
The simulations suggest that an optimal equilibrium can be reached when universities increase faculty inventors' income and rewards, and pharmaceutical companies set appropriate transaction prices, leading to a higher transformation success rate.
Limitations and Future Work
The authors acknowledge several limitations:
- Difficulty in Predicting Success Rate: The transformation success rate is hard to predict accurately before a transaction, complicating decision-making.
- Limited Scope of Parameters: The model primarily focuses on parameters directly related to the game subjects' strategies, potentially overlooking other influential factors.
- Asymmetric Information: While addressed, the full implications of incomplete information and risk preferences are not exhaustively explored.
Future research directions suggested include:
- Incorporating other factors like risk preference, contract details, patent ownership systems, and university performance evaluation systems.
- Expanding the model to include government policy support, as innovation is a multi-stakeholder effort.
- Developing multi-subject participation models for a more comprehensive understanding.
Summary updated